GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Biosensors Inc (ASX:UBI) » Definitions » Gross Margin %

Universal Biosensors (ASX:UBI) Gross Margin % : 88.95% (As of Dec. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Universal Biosensors Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Universal Biosensors's Gross Profit for the three months ended in Dec. 2024 was A$1.18 Mil. Universal Biosensors's Revenue for the three months ended in Dec. 2024 was A$1.32 Mil. Therefore, Universal Biosensors's Gross Margin % for the quarter that ended in Dec. 2024 was 88.95%.


The historical rank and industry rank for Universal Biosensors's Gross Margin % or its related term are showing as below:

ASX:UBI' s Gross Margin % Range Over the Past 10 Years
Min: 19.45   Med: 64.15   Max: 96.38
Current: 63.69


During the past 13 years, the highest Gross Margin % of Universal Biosensors was 96.38%. The lowest was 19.45%. And the median was 64.15%.

ASX:UBI's Gross Margin % is ranked better than
67.49% of 806 companies
in the Medical Devices & Instruments industry
Industry Median: 52.81 vs ASX:UBI: 63.69

Universal Biosensors had a gross margin of 88.95% for the quarter that ended in Dec. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Universal Biosensors was 16.20% per year.


Universal Biosensors Gross Margin % Historical Data

The historical data trend for Universal Biosensors's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Biosensors Gross Margin % Chart

Universal Biosensors Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.45 36.45 47.27 64.60 63.70

Universal Biosensors Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.89 59.73 71.96 41.72 88.95

Competitive Comparison of Universal Biosensors's Gross Margin %

For the Medical Devices subindustry, Universal Biosensors's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Biosensors's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Universal Biosensors's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Universal Biosensors's Gross Margin % falls into.


;
;

Universal Biosensors Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Universal Biosensors's Gross Margin for the fiscal year that ended in Dec. 2024 is calculated as

Gross Margin % (A: Dec. 2024 )=Gross Profit (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=4 / 6.283
=(Revenue - Cost of Goods Sold) / Revenue
=(6.283 - 2.281) / 6.283
=63.70 %

Universal Biosensors's Gross Margin for the quarter that ended in Dec. 2024 is calculated as


Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=1.2 / 1.321
=(Revenue - Cost of Goods Sold) / Revenue
=(1.321 - 0.146) / 1.321
=88.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Universal Biosensors  (ASX:UBI) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Universal Biosensors had a gross margin of 88.95% for the quarter that ended in Dec. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Universal Biosensors Gross Margin % Related Terms

Thank you for viewing the detailed overview of Universal Biosensors's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Biosensors Business Description

Traded in Other Exchanges
N/A
Address
1 Corporate Avenue, Rowville, VIC, AUS, 3178
Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. It has one reportable segment: specialist biosensors company. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets.

Universal Biosensors Headlines

No Headlines